IKAROS facilitates antigen escape in the face of CD19- and CD22-targeted therapies for B-cell acute lymphoblastic leukemia
Pablo Domizi(Institute for Stem Cell Biology and Regenerative Medicine), Kara L. Davis(Stanford Medicine), Milton Merchant(Institute for Stem Cell Biology and Regenerative Medicine), Nirali N. Shah(National Institutes of Health), Robbie G. Majzner(Dana-Farber Cancer Institute), Bonnie Yates(National Institutes of Health), Astraea Jager(Institute for Stem Cell Biology and Regenerative Medicine), Kaithlen Zen B Pacheco(Stanford University), Sean C. Bendall(Stanford University), Reema Baskar(Stanford University), Allison Barz Leahy(Memorial Sloan Kettering Cancer Center), Charles G. Mullighan(St. Jude Children's Research Hospital), Crystal L. Mackall(Stanford University), Warren D. Reynolds(Stanford University), Bita Sahaf(Stanford University), Elena Sotillo(Stanford University), Brian J. Sworder(City Of Hope National Medical Center), Maria Caterina Rotiroti(Dana-Farber Cancer Institute), Sean A. Yamada‐Hunter(Stanford University), David M. Barrett(University of Montana), Stephan A. Grupp(Children's Hospital of Philadelphia), Regina M. Myers(Children's Hospital of Philadelphia), Hao‐Wei Wang(Fu Jen Catholic University), Jolanda Sarno(Institute for Stem Cell Biology and Regenerative Medicine), Yuxuan Liu(Nanchang University), Ash A. Alizadeh(California Institute for Regenerative Medicine)
Cited by 2
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k